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TGF-β-targeting structural and inflammatory cells has been implicated in the mechanisms leading 
to the inflammatory and restructuring processes in asthma, suggesting an impact of TGF-β1 signaling 
on the development and persistency of this disease. We investigated the potential early involvement 
of TGF-β1 activity in the immunological and molecular mechanisms underlying progression of 
inflammation in childhood asthma. We evaluated the levels of TGF-β1 in induced sputum supernatants 
(ISSs) and the expression of small mother cell against decapentaplegic (Smad) 2 and Smad7 proteins in 
induced sputum cells (ISCs) from children with intermittent asthma (IA), moderate asthma (MA) and 
control subjects (C). Furthermore, we investigated the regulatory role of TGF-β1 activity on eosinophil 
and neutrophil adhesion to epithelial cells using adhesion assay, and on the granulocyte expression of 
adhesion molecule CD11b/CD18 Macrophage-1 antigen (MAC-1), by flow cytometry. We found that the 
levels of TGF-β1 are increased in ISSs of IA and MA in comparison to C, concomitantly to the activation 
of intracellular signaling TGFβ/Smads pathway in ISCs. In MA, TGF-β1 levels correlated with the 
number of sputum eosinophils and neutrophils. Furthermore, we showed the ability of sputum TGF-β1 
to promote eosinophil and neutrophil adhesion to epithelial cells, and to increase the expression of  MAC-
1 on the granulocyte surface. This study shows the activation of TGFβ/Smad signaling pathway in the 
airways of children with IA and, despite the regular ICS treatment, in children with MA, and provides 
evidence for the contribution of TGF-β1 in the regulation of granulocyte activation and trafficking.
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Transforming growth factor-β (TGF-β) has 
been implicated in the mechanisms leading to 
the deposition of extracellular matrix proteins in 
the airways of asthmatic patients and is a likely 
candidate in contributing to the inflammatory 
processes and structural changes (1-3). TGF-β1 
is overexpressed in patients with asthma and is 
considered one of the major fibrogenic factors with 
potential immunomodulatory activities. TGF-β1 
protein is expressed by structural cells, such as 
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epithelial cells, fibroblasts, and smooth muscle cells, 
and also by inflammatory cells, such as neutrophils 
and eosinophils. The signaling cascade following 
TGF-β binding to its receptor complex is via the 
Smad pathway (4). The activated TGF-β receptor 
induces phosphorylation of Smad2 and Smad3 
which form heterooligomeric complexes with Smad 
4. The complexes then translocate to the nucleus and 
regulate transcription of many inflammatory genes. 
Inhibitory Smads, including Smad6 and Smad7, have 
been identified as intracellular antagonists of TGF-β 
signaling by preventing TGF-β receptor activation 
(4). Upregulation of Smad proteins has been found 
in the lungs of sensitized ovalbumin-exposed mice, 
indicating that Smad-mediated signaling may be 
important in pathophysiology of allergic diseases 
(5).
TGF-β1 is a cytokine that affects many different 
cell processes in airways of asthmatic patients 
by targeting structural and inflammatory cells, 
suggesting an impact of TGF-β1 signaling on 
the development of this disease. The presence of 
chronic inflammation in airways is associated with 
bronchial obstruction and with remodeling of the 
airways (6). Airway epithelial cells are central to 
the pathogenesis of asthma and the function of 
the airway epithelium is further modified by local 
inflammatory/immune signals often promoting 
eosinophilic and neutrophilic inflammation in asthma 
(7). Granulocyte trafficking is regulated by surface 
molecules, such as CD11b/CD18 macrophage-1 
antigen (MAC-1), that modulate the interaction with 
epithelial cells via intercellular adhesion molecules 
(ICAM-1), promoting granulocyte infiltration and 
survival in inflammatory sites (8).
It has been postulated that airway structural 
changes are the consequence of chronic inflammation, 
although there is evidence that suggests a dissociation 
between at least some of the inflammatory and 
remodeling airway events in childhood asthma 
(9, 10). In a previous study, we demonstrated that 
pro-remodeling process, although without defined 
effects, is initiated at the early steps of the disease, 
and is associated with airway inflammation, as 
demonstrated by the concomitant overexpression 
of  IL-8, MMP-9 and TIMP-1 in induced sputum of 
asthmatic children (11). However, relatively few data 
are available on the definition of the immunological 
and molecular mechanisms underlying progression 
of inflammation, and on the potential involvement of 
TGF-β1 activity in childhood asthma (11-14). 
The aim of the present study was to investigate, 
both ex vivo and in vitro, the immunomodulatory 
role of TGF-β1 on the regulation of inflammatory 
and structural cells in childhood asthma, using non-
invasive induced sputum method. We evaluated the 
levels of TGF-β1 in induced sputum supernatants 
and the expression of phosphorylated-Smad2 and 
Smad7 proteins in sputum cells from children with 
intermittent and moderate asthma. In addition, 
to further characterize the inflammatory and 
immunological events associated with the levels of 
TGF-β present in the airways of asthmatic children, 
we investigated, in vitro, the role of sputum TGF-β1, 
in the regulation of adhesion mechanisms of 
inflammatory cells to airway epithelium, and in the 
granulocyte activation and trafficking.
MATERIALS AND METHODS
Subjects
Forty asthmatic children were recruited from the 
outpatient clinic of the CNR. The diagnosis of asthma and 
the assessment of its severity and control were carried out 
at study entry according to Global Initiative for Asthma 
(15). Only 30 out of 40 asthmatic children were able to 
give suitable sputum samples and to be included in the 
study. 
Ten children had intermittent asthma (IA), treated 
with short-acting ß
2
agonists on demand during the last 3 
months; 20 children had moderate asthma (MA) treated 
with Fluticasone Propionate 250 µg (inhaler device Diskus 
[GlaxoSmithKline, UK]) plus Salmeterol 50 µg bid, for at 
least 3 months. This high dose of Fluticasone Propionate 
was used to control the disease, at least considering the 
clinical and functional parameters. The control group 
consisted of seven healthy children (C). 
The study was approved by the Istitutional Ethics 
Committee of the Policlinic Hospital of Palermo 
University and complied with the Declaration of Helsinki. 
Written informed consent was obtained from the parents 
of the patients enrolled in the study.
Clinical assessment and compliance of patients 
Pulmonary function tests were performed as 
recommended by the American Thoracic Society (16). 
Forced expiratory volume in one second (FEV
1
), forced 
vital capacity (FVC) were measured according to ATS 
guidelines and the best of 3 technically acceptable and 
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the manufacturer’s instructions. In order to measure 
biologically active TGF-β1, the samples were acidified 
using HCl for 1 h (22). After acidification the samples were 
neutralized to pH 7.0–7.4 with NaOH and measurements 
of TGF-β1 were performed immediately. The detection 
limit of the assay was 0.05 ng/ml. The TGF-β1 assay 
was validated in line with European Respiratory Society 
recommendations (23), assessing the effect of DTT on the 
recovery of exogenous recombinant TGF-β1 (500pg/ml) 
spiked in sputum samples from IA (n=3) and MA (n=3). 
The recovery of spiked TGF-β1 samples was 90±5.6%.
Immunocytochemistry analysis
After thawing, immunocytochemical analyses for 
phosphorylated Smad2 and Smad7 proteins, were 
evaluated in induced sputum cells (ISCs) using the 
labeled streptavidin-biotin method (Alkaline phosphatase 
Rabbit/Mouse/Goat; Universal LSAB + kit; Dako, 
Glostrup, Denmark), as previously described (11). Anti-
phosphorylated Smad2 and anti-Smad7 antibodies (Cell 
Signalling Technology, Inc, MA, USA) were diluted 1:50. 
Isolation of peripheral blood granulocytes
Peripheral blood granulocytes (PBG) were isolated 
from healthy child donors by means of dextrane 
sedimentation and centrifugation over Ficoll cushion, as 
previously described (24). 
Eosinophil and neutrophil separation
In order to perform adhesion assay, neutrophils 
and eosinophils were separated from the total PBG, 
by immunomagnetic cell sorting (25). Briefly, CD16+ 
neutrophils were magnetically labeled with CD16 
microbeads (Miltenyi Biotec). Then the cell suspension 
was loaded onto a column placed in the magnetic field of 
a magnetic cell sorting separator (Miltenyi Biotec). The 
magnetically labeled CD16+ cells were retained on the 
column and the unlabeled eosinophils run through, and 
this cell fraction was depleted of CD16+ neutrophils. After 
removal of the column from the magnetic field, CD16+ 
positive neutrophils were eluted as the positive selected 
cell fraction.
Epithelial cell cultures
16-HBE is a cell line that retains the differentiated 
morphology and function of normal airway epithelial 
cells. The cells represent a clonal diploid (2n=6) cell 
line isolated from human lung previously used to study 
the functional properties of bronchial epithelial cells in 
inflammation and repair processes. 16-HBE cells were 
cultured as adherent monolayers in Eagle’s minimum 
essential medium (MEM) supplemented with 10% heat-
inactivated (56°C, 30 min) fetal bovine serum (FBS), 
reproducible manoeuvres was retained (16). Atopic status 
was assessed by skin prick tests (17) to aeroallergens 
commonly present in the Mediterranean area, and total 
serum IgE measurements. The compliance to treatment 
was assessed by checking the inhalation technique. We 
also measured basal plasma cortisol concentrations at 
8:00a.m. by electrochemiluminescence. Results were 
expressed in nanomolar concentrations, and adherence 
to inhaled corticosteroids was considered satisfactory if 
cortisol was less than 100 nM (18, 19). 
Sputum induction and processing
Each subject underwent spirometry before the 
beginning of the procedure. If FEV
1
 was over 75% of 
predicted at baseline and the child had not used a short-
acting ß2-agonist within the previous 6 h, we performed 
the procedure without premedication. Patients were 
exposed to an aerosol of 4% hypertonic saline solution, 
monitoring the assessment of bronchial reactivity, as 
described elsewhere (11, 20). 
Sputum processing was performed according to 
European Respiratory Society recommendation (21). 
Sputum was collected in previously weighed 50-ml 
sterile ampoules. The volume of the induced sputum 
was previously determined, and an equal volume of 
DTT (0.1% in saline; Sigma, St. Louis, MO) was added 
to the selected sputum. After homogenization, sputum 
samples were filtered (48-µm nylon cell strainer) and 
subsequently centrifuged at 800 g for 10 min to separate 
the supernatants from the cell pellet.  The supernatants 
were then aspirated and frozen at -80°C for the subsequent 
biochemical analysis. The cells obtained from induced 
sputum were then cytocentrifuged (Cytospin 2, Shandon 
Instruments, Runcorn, UK) and stained with Diff-Quick 
(Merz-Dade, Dudingen, CH). Slides were read blindly 
by two independent investigators and differential cell 
counts were expressed as a percentage of 400 cells. The 
cytospins for immunocytochemistry were prepared on 
3-aminopropyltriethoxysilane (APTEX)-coated slides 
by adding 100 µl of cell suspension (5x105 cells/ml) 
into Shandon II cytocentrifuge cups and centrifuging 
at 180 g for 5 min. The air-dry slides were fixed in 
paraformaldehyde-lysine-periodate (PLP) for 30 min and 
in 15% sucrose in Dulbecco’s PBS for 30 min. The slides 
were stored at -80°C until use for immunocytochemical 
staining. 
 
Measurement of TGF-β1
Determinations of TGF-β1 were assessed in induced 
sputum supernatants (ISSs) recovered from C, IA and MA 
children, using commercially available specific enzyme-
linked immunoadsorbent assay kit (US Biological, 
and Amersham International plc, UK), according to 
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concentration used for the induced sputum processing. At 
the end of the incubation time, granulocytes were assessed 
as described below for macrophage-1 antigen (MAC-1) 
CD11b/CD18 expression.   
Flow cytometry for MAC-1 expression 
Granulocytes were washed twice in PBS (containing 
1% FCS and 0.02% Na-azide) and thereafter stained and 
subjected to flow cytometric analysis. The expression of 
MAC-1 on granulocytes was evaluated by flow-cytometry 
analyses by direct label immunofluorescence by a FACS 
Calibur™ flow cytometer (Becton Dickinson, CA, 
USA), as previously described, using (RPE)-conjugated 
mouse monoclonal antibody direct against an Anti-
Human CD11b/CD18 (MAC-1) (DAKO A/S, Glostrup, 
Denmark). Granulocytes were gated by forward and side 
scatter and analysis was carried out on  50,000 acquired 
events for each sample. Results of flow cytometry were 
expressed as percentage of positive cells.
Statistical analysis
Statistical comparisons in order to test differences 
between the three groups (C, IA, MA) were made by use 
of the Kruskall-Wallis test followed by Bonferroni’s test 
correction for multiple comparisons. Data were expressed 
as median and inter quartile range. Correlations were 
calculated according to Spearman Rank test. ANOVA 
and unpaired t-test was used for the analysis of the data 
obtained from in vitro experimental conditions. Data were 
expressed as mean ± S.D. 
RESULTS
Demographic and functional characteristics of 
patients
The demographic and functional characteristics 
of patients are reported in Table I. No statistically 
significant differences were found among the three 
study groups in terms of FEV
1
 values indicating that, 
on the basis of this parameter, the asthmatic patients 
were functionally under control. We observed a 
significant FEV
1
/FVC decline in MA in comparison 
to C, and in MA in comparison to IA. 
Total and differential cell counts in induced 
sputum samples
The percentage of eosinophils in induced 
sputum samples was significantly higher in IA and 
MA than in C (Table II). The IA and MA also had 
a significantly increased percentage of sputum 
neutrophils and a significantly decreased percentage 
1% MEM (non-essential aminoacids, Euroclone), 2 mM 
L-glutamine and gentamicin 250 µg/ml at 37°C in a 
humidified 5% CO2 atmosphere. 
16-HBE stimulation for eosinophil and neutrophil 
adhesion
16-HBE (70,000 cells/well) were plated in standard 
24-well culture plates in MEM 10% FCS and grown to 
confluence. After 24 h with MEM 1% FCS, medium was 
replaced and 16-HBE cells were stimulated with ISSs 
(10% in fresh MEM 1% FCS) from C, IA and MA for 
24 h. To determine the contribution of TGF-β1 present 
in ISSs in regulating eosinophil and neutrophil adhesion 
capacity, ISSs from 5 C, 6 IA and 6 MA were pretreated 
with or without a monoclonal anti-TGF- β1 antibody (4 
µg/ml) (R&D Systems Europe Ltd, Abingdon, UK) for 1 
h at 4°C to neutralize sputum TGF- β1 activity, before co-
incubation with 16-HBE. 
Adhesion assay
Eosinophils and neutrophils were purified as described 
above, resuspended in PBS (2 x 106/ml) and  labeled for 
45 min at 37°C with an equal volume of the fluorochromic 
dye SFDA (50 µg/ml) (Molecular Probes). After labelling 
cells were washed, resuspended in PBS (0.4 x 106/ml) and 
co-incubated with epithelial cells in 24-well culture plates. 
Medium containing ISSs, or DTT alone, was removed 
from the 16-HBE cultures, before the addition of labeled 
eosinophils or neutrophils.
The plates were incubated at 37°C for 25 min to allow 
eosinophils and neutrophils to contact and to adhere to the 
confluent 16-HBE, and total fluorescence was measured 
using an excitation wavelength of 485 nm and monitoring 
emission at 530 nm in a Wallac 1420 Victor multilabel 
counter (PerkinElmer Life and Analytical Sciences-
Wallac OY, Turku, Finland). Later, non-adherent cells 
were removed by washing and fluorescence was measured 
to evaluate bound cells. Adhesion was expressed as 
percentage of the fluorescence ratio of bound cells on 
total cells. All test points were performed in triplicate. The 
baseline values represent the adhesion of eosinophils and 
neutrophils to unstimulated 16-HBE.
Peripheral blood granulocytes stimulation for MAC-1 
expression
Granulocytes were resuspended and cultured at the 
concentration of 4x105/ml in vials with fresh RPMI 1% 
FCS. ISSs from 5 C, 6 IA and 6 MA were pretreated with 
a monoclonal anti-TGF-β1 antibody (4 µg/ml) for 1 h at 
4°C to neutralize sputum TGF-β1 activity. Thereafter, 
granulocytes were stimulated for 2 h with selected ISSs 
pretreated or not with anti-TGFβ neutralizing antibody, or 
incubated with medium containing DTT alone at the same 
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Table I. Demographic and functional characteristics of subjects.     
Intermittent Moderate pValue    
Controls Asthma Asthma C/IA C/MA IA/MA 
        
Number 7 10 20    
       
Sex, M/F 5/2 6/4 12/8    
       
Age 10(9-11) 8(7-10) 11(10-13) NS NS NS 
       
Total IgE(KU) 20(15-20) 522(308-857) 536(387-770) p<0.002 p<0.001 NS 
       
FEV1(%)  101(100-103) 96(94.5-104) 92(89-96) NS NS NS 
       
FEV1/FVC(%)  100(98.5-105) 93(88-109) 85(74-86) NS p<0.001 p<0.005
       
Asthma duration, yr NA 4(3-6) 6(4.5-7)   NS 
       
Cortisol (nM)† 226(190-280) 194(170-225) 66(58-95) NS p<0.001 p<0.004
       
          
           
       
Results are expressed as median (25-75 percentiles).      
† Cortisol levels at study entry.       
Table I. Demographic and functional characteristics of subjects.
Results are expressed as median (25-75 percentiles).
† Cortisol levels at study entry.
          
Table II. Total and differential count of cells from induced sputum.    
    
     C IA MA     
         C/IA C/MA IA/MA
            
Total cell counts (106cells/ml) 0.8(0.5-1.5) 1.5(0.8-1.9) 1.2 (0.6-1.8) NS NS NS 
        
 Squamous cells (%) 2.5(2-5) 2.5(1-4) 2(0-3) NS NS NS 
        
 Macrophages (%) 90(89-95) 59.5(49.5-70.6) 58.5(25-63) ** ** NS 
        
 Eosinophils (%) 0 5.5(3-8) 4.5(3-9) ** ** NS 
        
 Neutrophils (%) 8(4-11) 28(6-33) 31.5(7-36) * ** NS 
        
 Lymphocytes (%) 0(0-0.5) 3.5(1-3) 2.5(1.5-4.5) NS NS NS 
          
Epithelial cells (%) 0 (0-2.6) 0.5 (0-2) 1(0-1.8) NS NS NS 
                  
                  
Results are expressed as medians (25-75 percentiles) in respect to total cell counts. 
**, p<0.001;   * , p<0.01; NS:  not significant    
   
   
Table II. Total and differential count of cells from induced sputum.
Results are expressed as medians (25-75 percentiles) in respect to total cell counts.
**, p<0.001;   * , p<0.01; NS:  not significant
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subjects. The concentrations of TGF-β1 were 
significantly increased in both IA and MA when 
compared to C (Fig. 1).
Phosphorylated-Smad2 and Smad7 protein 
expression in ISCs
We performed immunocytochemistry analyses on 
ISCs to determine the expression of phosphorylated 
Smad2 (p-Smad2) and Smad7 proteins. The 
percentage of induced sputum cells positive for 
of macrophages when compared to C (Table II). The 
median viability of the cells obtained from induced 
sputum samples was 79% (25 to 75 percentiles: 70 to 
87) in C and 74% (25 to 75 percentiles: 68 to 80) in 
asthmatic children.
Detection of TGF-β1
We measured the concentrations of the 
biologically active TGF-β1 in the induced sputum 
supernatants recovered from the three groups of 
Fig. 1. Measurements of TGF-β1 in induced sputum supernatants (ISSs). Assessment of the  concentrations 
of TGF-β1 in sputum supernatants of healthy control children (C), intermittent asthmatic (IA) and moderate 
asthmatic children (MA). Individual data are shown. Horizontal lines represent the median.         
Table III. Expression of p-Smad2 protein by different cell types.
     C IA MA     
         C/IA C/MA IA/MA 
         
Total cells  1.5(0.5-1.5) 42.5(13-40) 48(16-58) NS NS NS 
        
 Macrophages (%) 0.5(0-1) 10(8-15) 16(25-63) ** ** NS 
        
 Eosinophils (%) 0 (0-0.5) 15(10-23 ) 12(8.5-23) ** ** NS 
        
 Neutrophils (%) 0 (0-0.5) 16(13-23) 18(12-24) ** ** NS 
        
 Lymphocytes (%) 0(0-0.5) 2(0.6-2.1) 2.5(1.5-4.5) NS NS NS 
                
         
Results are expressed as median (25-75 percentiles) of positive different cell types in respect to total posit
**, p<0.001        
        
        
Table IV. Expression of Smad7 protein by different cell types.
     C IA MA     
         C/IA C/MA 
         
Total cells 20(16-23) 24(20-25) 23(15-30) NS NS 
        
 Macrophages (%) 10(2-8) 6.5(1-8) 6(3-7) NS NS 
        
 Eosinophils (%) 4(3-8) 8(4-14) 7(5-9) NS NS 
        
 Neutrophils (%) 4.5(2-9) 7(3-12) 8(7-11) NS NS 
        
 Lymphocytes (%) 2(0-2) 2.5(1-4) 2(1.5-3) NS NS 
              
        
Results are expressed as median (25-75 percentiles) of positive different cell types in respect to total posit
**, p<0.001      
Table III. Expression of p-Smad2 protein by different cell types.
Results are expressed as median (25-75 percentiles) of positive different cell types in respect to total positive cells.
**, p<0.001
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nucleus of IA and MA. No differences were detected 
between the two groups of asthmatic patients. The 
percentage of sputum macrophages, eosinophils and 
p-Smad2 (Fig. 2A), were significantly higher in 
children with IA and MA than in C. We found the 
presence of p-Smad2 protein in both cytosol and 
         
Table III. Expression of p-Smad2 protein by different cell types.
     C IA MA     
         C/IA C/MA IA/MA 
         
Total cells  1.5(0.5-1.5) 42.5(13-40) 48(16-58) NS NS NS 
        
 Macrophages (%) 0.5(0-1) 10(8-15) 16(25-63) ** ** NS 
        
 Eosinophils (%) 0 (0-0.5) 15(10-23 ) 12(8.5-23) ** ** NS 
        
 Neutrophils (%) 0 (0-0.5) 16(13-23) 18(12-24) ** ** NS 
        
 Lymphocytes (%) 0(0-0.5) 2(0.6-2.1) 2.5(1.5-4.5) NS NS NS 
                
         
Results are expressed as median (25-75 percentiles) of positive different cell types in respect to total posit
**, p<0.001        
        
        
Table IV. Expression of Smad7 protein by different cell types.
     C IA MA     
         C/IA C/MA 
         
Total cells 20(16-23) 24(20-25) 23(15-30) NS NS 
        
 Macrophages (%) 10(2-8) 6.5(1-8) 6(3-7) NS NS 
        
 Eosinophils (%) 4(3-8) 8(4-14) 7(5-9) NS NS 
        
 Neutrophils (%) 4.5(2-9) 7(3-12) 8(7-11) NS NS 
        
 Lymphocytes (%) 2(0-2) 2.5(1-4) 2(1.5-3) NS NS 
              
        
Results are expressed as median (25-75 percentiles) of positive different cell types in respect to total posit
**, p<0.001      
Table IV. Expression of Smad7 protein by different cell types.
Results are expressed as median (25-75 percentiles) of positive different cell types in respect to total positive cells.
**, p<0.001
Fig. 2. Immunocytochemistry for phosphorylated-Smad2 (p-Smad2) (Panel A) and Smad7 (Panel C) in induced sputum 
cells from healthy C subjects (n=7), IA (n=10) and MA (n=14) children (magnification at x40). Panels B and D, individual 
data are shown (percentage of positive cells). Horizontal lines represent the median.
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TGF-β1 antibody significantly reduced the ability 
of eosinophils and neutrophils to adhere to epithelial 
cells (Fig. 3B and Fig. 4B).
Correlations 
In moderate asthmatic children, sputum TGF-β1 
levels positively correlated with the number of 
sputum eosinophils and neutrophils (p=0.004, 
Rho=0.65; p=0.002, Rho=0.88, respectively) (Fig. 
5A and 5B). In intermittent asthmatic children, no 
significant correlations were found between sputum 
TGF-β1 levels and the number of sputum eosinophils 
and neutrophils.
Effect of ISSs on the expression of MAC-1 in 
granulocytes
We showed that  MAC-1 expression was 
neutrophils positive for p-Smad2 was significantly 
higher in IA and MA than in C (Table III). 
Similar levels of Smad7 protein expression were 
found  in sputum cells from C, IA and MA, with no 
significant differences between the study groups 
(Fig. 2B and Table IV). 
Effect of ISSs on eosinophil and neutrophil adhesion 
to 16-HBE
The stimulation of 16-HBE with ISSs obtained 
from intermittent and moderate asthmatic children, 
promoted higher levels of adherent eosinophils and 
neutrophils in comparison to 16-HBE stimulated 
with ISSs from control children or medium alone 
(Fig. 3A and Fig. 4A). DTT alone had no effects 
on eosinophil and neutrophil adhesion (data not 
shown). ISS neutralizing pre-treatment with anti-
Fig. 3. Adhesion of eosinophils to 16-HBE stimulated with ISSs. A) 16-HBE were stimulated with ISSs obtained from 
C (n=5), IA (n=6) and MA (n=6) for 24 h and then co-incubated with eosinophils, obtained from normal donors, for 
25 min at 37°C before the eosinophil adhesion assay. Results are expressed as percentage of adhering eosinophils (% 
of fluorescence). B) 16-HBE were stimulated with ISSs obtained from C (n=5), IA (n=6) and MA (n=6), treated with 
or without a monoclonal neutralizing anti-TGF-β1 antibody for 1 h, before their addition to 16-HBE for 24 h. 16-HBE 
cells were then incubated with eosinophils obtained from normal donors for 25 min at 37°C before eosinophil adhesion 
assay. Results are expressed as percentage of inhibition of eosinophil adhesion vs untreated ISSs. The bars represent the 
means±SD of values. **p<0.001 vs C and baseline.
R. GAGLIARDO ET AL.
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Fig. 4. Adhesion of neutrophils to 16-HBE stimulated with ISSs. A) 16-HBE were stimulated with ISSs obtained from 
C (n=5), IA (n=6) and MA (n=6) for 24 h and then co-incubated with neutrophils, obtained from normal donors, for 
25 min at 37°C before the neutrophil adhesion assay. Results are expressed as percentage of adhering neutrophils (% 
of fluorescence). B) 16-HBE were stimulated with ISSs obtained from C (n=5), IA (n=6) and MA (n=6), treated with 
or without a monoclonal neutralizing anti-TGF-β1 antibody for 1 h, before their addition to 16-HBE for 24 h. 16-HBE 
cells were then incubated with neutrophils obtained from normal donors for 25 min at 37°C before neutrophil adhesion 
assay. Results are expressed as percentage of inhibition of neutrophil adhesion vs untreated ISSs. The bars represent the 
means±SD of values. *p<0.01 vs C and baseline; **p<0.001 vs C and baseline.
Fig. 5. Correlations between sputum TGF-β1 concentrations and sputum eosinophils (A), and between sputum TGF-β1 
concentrations and sputum neutrophils (B), in moderate asthmatic children. Correlations were calculated according to 
Spearman test.
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regulation of adhesion mechanisms of inflammatory 
cells to airway epithelium, showing its potential role 
in the granulocyte activation and trafficking in the 
airways of asthmatic children.
TGF-β1 has a key role in orchestrating both 
inflammatory and remodeling processes in asthma 
(26). In bronchial biopsies of asthmatic children, the 
involvement was observed of TGF-β1 in changes of 
local tissue microenvironment promoting epithelial 
stress, structural pre-modeling and production 
of pro-inflammatory stimuli (9). Increased levels 
of TGF-β1 were observed in induced sputum of 
mild to moderate adult asthmatics (27) and in 
bronchoalveolar lavage fluid of children with 
severe asthma (28). The major activity of TGF-β1 
is associated with eosinophils, although the action 
of TGF-β1 is also associated with other cell types, 
such as neutrophils, involved in the pathogenesis 
increased in granulocytes stimulated with ISSs from 
IA and MA patients when compared to granulocytes 
stimulated with ISSs from C subjects. DTT alone 
had no effects on the granulocyte MAC-1 surface 
expression (data not shown). The pre-incubation of 
ISSs from IA and MA with anti-TGF-β1 neutralizing 
antibody reduced the expression of MAC-1 on 
granulocyte surfaces  (Fig. 6A and 6B). 
DISCUSSION
In the present study we show that the levels 
of TGF-β1 are increased in induced sputum of 
intermittent and moderate asthmatic children 
in comparison to controls, concomitantly to the 
activation of intracellular signaling TGFβ/Smads 
pathway in induced sputum cells. Furthermore, 
we demonstrate the contribution of TGF-β1 in the 
Fig. 6. Flow cytometric analysis for MAC-1 protein surface expression in peripheral blood granulocytes (PBG) 
stimulated with ISSs from C, IA and MA. A) 16-HBE were stimulated for 24 h at 37°C with ISSs from C (n=5 ), IA (n=6) 
and MA (n=6), pretreated with or without neutralizing anti-TGFβ1 antibody for 1 h. The bars represent the means±SD 
of the percentage of positive cells. ##p<0.001 vs C; *p<0.01, ** p<0.001, before and after anti-TGFβ1 treatment. B) 
Representative flow cytometry of MAC-1 protein of each experimental condition (overlay of fluorescence intensity). The 
left peaks indicate representative flow cytometry of  negative control (Dako, Denmark A/S).                                               
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had similar levels in IA, MA  and C subjects. These 
results indicate that disturbed negative regulation 
of TGF-β/Smad signaling could exist in airways of 
IA and MA children, thus impairing the excess of 
Smad2-mediated activation. Moreover, the activation 
of TGFβ/Smad pathway in MA children, despite the 
ongoing ICS therapy, supports the concept that some 
patients display not completely inhibited molecular 
mechanisms of TGFβ/Smad pathway.
 Airway epithelial cells respond to the 
cytokine milieu driving airway immune response and 
through the expression of adhesion molecules, may 
contribute to the recruitment of inflammatory cells, 
such as eosinophils and neutrophils, leading to the 
pathophysiological changes typical of the asthmatic 
airways (7, 9). Based on this knowledge, we evaluated 
the immunomodulatory role of TGF-β1 in childhood 
asthma, and its relationship with inflammatory and 
structural cells by investigating the interaction of 
sputum TGF-β1 with eosinophils and neutrophils, 
through the commitment of bronchial epithelium. 
We observed that the stimulation of human bronchial 
epithelial cells (16-HBE) with ISSs from IA and 
MA children promotes an increment of eosinophil 
and neutrophil adhesion to bronchial epithelial 
cells, in comparison to ISSs from C children. These 
findings suggest that the mechanisms of interactions 
between airway inflammatory microenvironment 
and epithelial cells facilitate the origin of signals 
promoting eosinophil and neutrophil recruitment. 
Furthermore, the depletion of TGF-β1, obtained 
with the pre-treatment of ISSs with anti-TGF-β1, 
reduced the percentage of adhesion of eosinophils 
and neutrophils to 16-HBE. Our results suggest that 
higher levels of bronchial TGF-β1, in childhood 
asthma, might be involved in the regulation of 
cellular adhesion mechanisms involving activated 
granulocytes and airway epithelium. 
Corticosteroids are considered as first-line anti-
inflammatory treatment, especially in chronic 
asthma, although the increase of TGF-β1 levels in 
vivo was shown to persist despite corticosteroid 
treatment in moderate to severe adult asthma (33). 
These observations suggested that anti-inflammatory 
therapy does not completely prevent inflammatory 
and remodeling processes associated with TGF-β1. 
We found that in moderate asthmatic children the 
depletion of TGF-β1 from ISSs showed a reduced 
of asthma and persistence of inflammatory process 
(26). Eosinophils are recognized as major cellular 
mediators of airway inflammatory processes in 
asthma, although increased neutrophils are a feature 
of airway inflammation in a subgroup of adult 
and pediatric asthmatic patients with more severe 
disease (11, 29). In this scenario, eosinophilic 
and neutrophilic inflammation are not mutually 
exclusive in asthma, suggesting that the complex 
immunopathogenesis of inflammation is the result 
of immunological and molecular heterogeneity (11, 
14, 30). Accordingly, our findings show increased 
levels of TGF-β1, in ISSs obtained from IA and 
MA children, compared with C subjects, together 
with the increased number of sputum eosinophils 
and neutrophils. These observations suggest that 
inflammation and pro-remodeling markers, such 
as TGF-β1, could be present simultaneously in 
the airways of asthmatic children. Although no 
significant differences in TGF-β1 levels were 
observed between IA and MA children, we identified 
the presence of a sub-population of MA with high 
sputum concentrations of TGF-β1, despite the 
regular inhaled corticosteroid (ICS) treatment. The 
precise initiation and progression of inflammatory 
events and the factors responsible for the variable 
efficacy of corticosteroid treatment are unknown 
in the airways of asthmatics. In accordance with 
our previous results (11, 14), these findings further 
suggest the presence of a biological heterogeneity in 
children with moderate asthma and the need to better 
characterize, especially in children, the immunologic 
and inflammatory mechanisms driving the asthma 
progression associated with TGF-β1.    
 The intracellular signaling TGFβ/Smads 
pathway and its relationship with airway inflammation 
have been extensively studied in human and in 
animal models (5, 31). Elevated phosphorylated 
Smad-2 levels have been demonstrated in bronchial 
biopsies obtained from adult asthmatic subjects, 
indicating that TGF-β1 signaling downstream from 
the receptor, is enhanced in asthma (31). Altered 
expression of Smad7 has been associated with 
inflammatory and fibrotic disorders with a regulator 
negative-feedback mechanism for TGF-β signaling 
(32). We observed that TGF- β/Smad2 pathway is 
active in airway sputum cells from children with IA 
and MA, while the expression of inhibitor Smad7 
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